Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer

International Immunopharmacology

Volumn 14, Issue 3, 2012, Pages 252-260

  Zhang, Pei ^a,b   Wang, Jinyan ^a   Wang, Danan ^a   Wang, Huan ^a   Shan, Fengping ^a   Chen, Liudan ^a   Hou, Ying ^a   Wang, Enhua ^a   Lu, Chang Long ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Ag85A; Bladder cancer; Dendritic cells; Vaccine

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RAF PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ONCOGENE MYC; PHENOTYPE; PRIORITY JOURNAL; THERAPY EFFECT; TUMOR CELL; TUMOR IMMUNITY; UPREGULATION;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, BACTERIAL; CANCER VACCINES; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DENDRITIC CELLS; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; URINARY BLADDER NEOPLASMS;

EID: 84865301881     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.07.014     Document Type: Article

References (36)

1. S.A. Pou, A.R. Osella, and P. Diaz Mdel Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986-2006) Cancer Causes Control 22 2011 407 415
2. A. Böhle, and S. Brandau Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer J Urol 170 2003 964 969
3. R.J. Sylvester, A.P. van der MEIJDEN, and D.L. Lamm Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
4. A.R. Zlotta, J.P. Van Vooren, O. Denis, A. Drowart, and M. Daffé What are the immunologically active components of bacille Calmette-Guerin in therapy of superficial bladder cancer? Int J Cancer 87 2000 844 852
5. E. Gilboa DC-based cancer vaccines J Clin Invest 117 2007 1195 1203
6. A. Draube, N. Klein-González, S. Mattheus, C. Brillant, M. Hellmich, and A. Engert Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis PLoS One 20 6 2011 e18801
7. F.J. Hsu, C. Benike, F. Fagnoni, T.M. Liles, D. Czerwinski, and B. Taidi Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat Med 2 1996 52 58
8. N. Nakai, J. Asai, E. Ueda, H. Takenaka, N. Katoh, and S. Kishimoto Vaccination of Japanese patients with advanced melanoma with peptide, tumor lysate or both peptide and tumor lysate-pulsed mature, monocyte-derived dendritic cells J Dermatol 33 2006 462 472
9. L. Fong, Y. Hou, A. Rivas, C. Benike, A. Yuen, and G.A. Fisher Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy Proc Natl Acad Sci U S A 98 2001 8809 8814
10. K. Palucka, H. Ueno, G. Zurawski, J. Fay, and J. Banchereau Building on dendritic cell subsets to improve cancer vaccines Curr Opin Immunol 22 2010 258 2634
11. K. Bennaceur, J.A. Chapman, J.L. Touraine, and J. Portoukalian Immunosuppressive networks in the tumour environment and their effect in dendritic cells Biochim Biophys Acta 1795 2009 16 24
12. A.J. Troy, P.J. Davidson, C.H. Atkinson, and D.N. Hart CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated J Urol 161 1999 1962 1967
13. E.G. Engleman Dendritic cell-based cancer immunotherapy Semin Oncol 30 2003 23 29
14. T. Jakob, P.S. Walker, A.M. Krieg, M.C. Udey, and J.C. Vogel Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA J Immunol 161 1998 3042 3049
15. T. Sparwasser, E.S. Koch, R.M. Vabulas, K. Heeg, G.B. Lipford, and J.W. Ellwart Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells Eur J Immunol 28 1998 2045 2054
16. J.T. Belisle, V.D. Vissa, T. Sievert, K. Takayama, P.J. Brennan, and G.S. Besra Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis Science 276 1997 1420 1422
17. K. Huygen, J. Content, O. Denis, D.L. Montgomery, A.M. Yawman, and R.R. Deck Immunogenicity and protective efficacy of a tuberculosis DNA vaccine Nat Med 2 1996 893 898
18. M. Borremans, L. de Wit, G. Volckaert, J. Ooms, J. de Bruyn, and K. Huygen Cloning, sequence determination, and expression of a 32-kilodalton- protein gene of Mycobacterium tuberculosis Infect Immun 57 1989 3123 3130
19. D.L. Montgomery, K. Huygen, A.M. Yawman, R.R. Deck, C.M. Dewitt, and J. Content Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA Cell Mol Biol (Noisy-le-Grand) 43 1997 285 292
20. O. Denis, A. Tanghe, K. Palfliet, F. Jurion, T.P. van den Berg, and A. Vanonckelen Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4 + and CD8 + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection Infect Immun 66 1998 1527 1533
21. H. Nakano, T. Nagata, T. Suda, T. Tanaka, T. Aoshi, and M. Uchijima Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A Vaccine 24 2006 2110 2119
22. J.P. Tarrant, M.J. Walsh, M.C. Blanchard, T.D. Lee, D.W. Hoskin, and C.A. Giacomantonio Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial Ag85A Int J Oncol 25 2004 1693 1699
23. Z. Shen, G. Reznikoff, G. Dranoff, and K.L. Rock Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules J Immunol 158 1997 2723 2730
24. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
25. A.Y. Huang, P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens Science 264 1994 961 965
26. Z. Qin, G. Noffz, M. Mohaupt, and T. Blankenstein Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene modified tumor cells J Immunol 159 1997 770 776
27. D.I. Gabrilovich, J. Corak, I.F. Ciernik, D. Kavanaugh, and D.P. Carbone Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 3 1997 483 490
28. J.D. Beatty, S. Islam, M.E. North, S.C. Knight, and C.W. Ogden Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer? BJU Int 94 2004 1377 1383
29. S. Honda, Y. Sakamoto, M. Fujime, and R. Kitagawa Immunohistochemical study of tumor-infiltrating lymphocytes before and after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer Int J Urol 4 1997 68 73
30. B. Sander, O. Damm, B. Gustafsson, U. Andersson, and L. Håkansson Localization of IL-1, IL-2, IL-4, IL-8, and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin J Urol 156 1996 536 541
31. S.L. Baldwin, D.D. Souza, I.M. Orme, M.A. Liu, K. Huygen, and O. Denis Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A Tuber Lung Dis 79 1999 251 259
32. N. Dhar, V. Rao, and A.K. Tyagi Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis Med Microbiol Immunol 193 2004 19 25
33. R.C. Fields, K. Shimizu, and J.J. Mule Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo Proc Natl Acad Sci U S A 95 1998 9482 9487
34. M. Schnurr, P. Galambos, C. Scholz, F. Then, M. Dauer, and S. Endres Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines Cancer Res 61 2001 6445 6450
35. M.S. Mitchell, W. Harel, J. Kan-Mitchell, L.G. LeMay, P. Goedegebuure, and X.Q. Huang Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action Ann N Y Acad Sci 690 1993 153 166
36. S. Sharma, M. Stolina, J. Luo, R.M. Strieter, M. Burdick, and L.X. Zhu Secondary lymphoid tissue chemokine mediates T cell dependent antitumor responses in vivo J Immunol 164 2000 4558 4563